# LaunchCyte

> LaunchCyte is a VC fund in Pittsburgh backing Medical and Health Care. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Pittsburgh, United States
- Total investments: 3
- Last investment: Dec 2012
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://launchcyte.com

LaunchCyte is a VC fund in Pittsburgh focused on Medical and Health Care. LaunchCyte creates life sciences companies. Since their founding in 2000, they have created six companies that offer unique technologies and products to improve healthcare and the human condition. They search for the most exciting technologies from leading research universities and form companies to commercialize the innovations.

## Contacts

5 contacts available for LaunchCyte. Shizune tracks 2 team members at LaunchCyte. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/launchcyte?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Health Care | 1 | 33% |
| Biotechnology | 1 | 33% |
| Health Diagnostics | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Series C | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Babs Carryer | Co-founder | 0 | — |
| Tom Petzinger | Co-Founder | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Knopp Biosciences | Knopp Biosciences is a drug discovery and development company that focuses on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership. The company targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetictesting. The company's goal is to accelerate and advance treatment, change the course of diseases, and improve the lives of the patients and their families.Knopp Biosciences was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania. | $30M | Series C | Dec 03, 2012 |  |
| Knopp Biosciences | Knopp Biosciences is a drug discovery and development company that focuses on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership. The company targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetictesting. The company's goal is to accelerate and advance treatment, change the course of diseases, and improve the lives of the patients and their families.Knopp Biosciences was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania. | $10M | Series B | Jan 22, 2008 |  |
| Knopp Biosciences | Knopp Biosciences is a drug discovery and development company that focuses on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership. The company targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetictesting. The company's goal is to accelerate and advance treatment, change the course of diseases, and improve the lives of the patients and their families.Knopp Biosciences was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania. | $10M | Series A | Jan 01, 2006 |  |

3 of 3 investments shown.

## Co-investors
- Kramer Capital Partners — VC Fund, 3 deals together
- [Saturn Partners](https://shizune.co/investors/profile/saturn-venture-partners) — VC Fund, 3 deals together
- [Biogen](https://shizune.co/investors/profile/biogen-idec) — VC Fund, 1 deal together
- [Innovation Works](https://shizune.co/investors/profile/innovation-works) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does LaunchCyte invest in?

LaunchCyte invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact LaunchCyte?

Public channels for LaunchCyte include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at LaunchCyte?

The team at LaunchCyte includes Babs Carryer (Co-founder) and Tom Petzinger (Co-Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co